Edition:
United States

Amphastar Pharmaceuticals Inc (AMPH.OQ)

AMPH.OQ on NASDAQ Stock Exchange Global Select Market

17.50USD
4:00pm EDT
Change (% chg)

$-0.18 (-1.02%)
Prev Close
$17.68
Open
$17.69
Day's High
$17.73
Day's Low
$17.30
Volume
52,462
Avg. Vol
86,020
52-wk High
$20.44
52-wk Low
$14.40

Chart for

About

Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company focuses primarily on developing, manufacturing, marketing and selling generic and injectable, inhalation and intranasal products. The Company has two segments: finished pharmaceutical products and active pharmaceutical ingredients (API) products.... (more)

Overall

Beta: 1.38
Market Cap(Mil.): $821.81
Shares Outstanding(Mil.): 46.61
Dividend: --
Yield (%): --

Financials

  AMPH.OQ Industry Sector
P/E (TTM): -- 28.54 30.58
EPS (TTM): -0.32 -- --
ROI: -3.97 13.15 12.84
ROE: -4.52 15.15 15.02

Amphastar cannot collect $100 mln during Momenta drug patent appeal - judge

A federal judge on Monday ruled that Amphastar Pharmaceuticals Inc must wait to collect a $100 million bond that Momenta Pharmaceuticals Inc and Sandoz Inc posted in a drug patent case it won until after an appellate court hears the dispute.

Jul 16 2018

BRIEF-Amphastar Pharmaceuticals Receives FDA Approval For Calcium Chloride Injection

* AMPHASTAR PHARMACEUTICALS RECEIVES FDA APPROVAL FOR CALCIUM CHLORIDE INJECTION

May 14 2018

Earnings vs. Estimates